Načítá se...
Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin
BACKGROUND: Doxorubicin (DOX) can cause cumulative cardiotoxicity in dogs, but the incidence of clinical cardiotoxicity in dogs receiving DOX has not been determined. HYPOTHESIS/OBJECTIVES: To determine if the duration of DOX infusion influences the incidence of cardiotoxicity, to characterize the i...
Uloženo v:
| Vydáno v: | J Vet Intern Med |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6430885/ https://ncbi.nlm.nih.gov/pubmed/30697816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.15414 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|